![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
TWO REPORTED CASES OF ONLY PRIMARY INTEGRASE INHIBITOR DRUG-CLASS RESISTANCE TRANSMISSION INCLUDING THE FIRST REPORTED CASE OF PRIMARY ELVITEGRAVIR RESISTANCE TRANSMISSION
|
|
|
"These are the first two documented cases of integrase only primary drug resistance transmission in antiretroviral naïve patients, including the first case of EVG only primary major drug resistance acquisition"
Reported by jules Levin
IDWeek 2016 Oct 23-26 New Orleans
Dr. Ricky K. Hsu M.D.1,2 , Erik P. Mortensen N.P.2
NYU Langone Medical Center1, AIDS Health Care Foundation New York2
![HIV1](../images/103116/103116-8/HIV1.gif)
![HIV2](../images/103116/103116-8/HIV2.gif)
![HIV3](../images/103116/103116-8/HIV3.gif)
![HIV4](../images/103116/103116-8/HIV4.gif)
![HIV5](../images/103116/103116-8/HIV5.gif)
![HIV6](../images/103116/103116-8/HIV6.gif)
![HIV7](../images/103116/103116-8/HIV7.gif)
![HIV8](../images/103116/103116-8/HIV8.gif)
![HIV9](../images/103116/103116-8/HIV9.gif)
![HIV10](../images/103116/103116-8/HIV10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|